After appendix has been removed for perforated appendicitis, patients will receive postoperative antibiotics. In the last 5 years, the literature has transitioned from a 3 -drug therapy to 2-drug therapy. Now there is a recent literature suggesting a single-drug therapy may be safe and adequate. In fact, using zosyn (piperacillin-tazobactam) as a single-drug therapy, there are additional benefits of simplicity, compliance, and lower infectious complications. Currently surgeons are already using both 2-drug regimen (ceftriaxone/metronidazole) and single-drug regimen (zosyn) interchangeable as both are FDA approved and regulated antibiotics for intra-abdominal infection. There is a clear need to compare outcomes between these two options.
The diagnosis of perforated appendicitis will be documented intraoperatively with photos of extraluminal fecal contents or visible holes on the appendix. Patients will be randomized to 121 in each arm. Postoperative antibiotic therapy option will be decided based on blinded sequence model. 30 day postoperative follow up visit or calls will be made to assess and collect infectious complications.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
162
Single drug therapy
Phoenix Children's Hospital
Phoenix, Arizona, United States
Children's Mercy Hospital
Kansas City, Missouri, United States
Number of Participants With a Postoperative Intra-abdominal Abscess
Intra-abdominal abscess documented by ultrasound or computerized tomography
Time frame: 30 days
Number of Participants With Postoperative Surgical Site Infection
surgical site infections including superficial port site infection
Time frame: 30 days
Number of Participants With a Postoperative Readmission
readmission within 30 days for any gastrointestinal complaints or infectious complications
Time frame: 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.